Gene Amplification Technologies Market Size Worth $30.80 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Nov. 15, 2021 /PRNewswire/ -- The global gene amplification technologies market size is expected to reach USD 30.80 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.0% from 2021 to 2028. The major factors driving the market are the expanding research in molecular diagnostics and genomics, the introduction of novel and advanced products, and the growing acceptance of personalized medicine.

Key Insights & Findings:

• By technology, the PCR-based amplification segment accounted for the largest revenue share in 2020 owing to its widespread use across various applications. The ongoing pandemic has also propelled the segment growth due to the rapidly growing demand for PCR detection kits
• The hybridization downstream application segment dominated the market in 2020 owing to the increasing usage of various gene multiplication technologies. The hybridization chain reaction is low cost, practical, and almost ready to use, thus supplementing the market growth
• Based on sample type, the single-cell sample is increasingly being used across various research settings. Single-cell PCR and fluorescent in-situ hybridization or FISH are used to identify the differences between populations of single cells
• The kits and reagents product segment captured the largest revenue share in 2020 owing to the vast product portfolio offered by the key entities and expanding research activities
• In terms of end use, the others segment consisting of hospitals, clinics, and diagnostics labs dominated the market in 2020. It has the highest penetration of various amplification technologies due to the impact of the ongoing COVID-19 pandemic. However, this segment exhibits a low growth rate as compared to other end-use segments
• The academic and research institutes end-use segment is expected to witness the fastest growth over the forecast period. The segment has a substantial penetration of amplification techniques

Read 185 page market research report, "Gene Amplification Technologies Market Size, Share & Trends Analysis Report By Technology, By Downstream Application, By Sample Type, By Product, By End Use, By Region, And Segment Forecasts, 2021 - 2028", by Grand View Research

Increasing investment in genomics by pharmaceutical and biotechnology companies is anticipated to drive the market significantly over the near future. In recent years, the biotechnology sector has witnessed a significant shift toward new drugs and treatments, genome sequencing-based medicines, and advancements in technologies, thereby propelling market growth.

Advancements in molecular diagnostic tools such as NGS, droplet digital PCR, and genome-wide sequencing with respect to reproducibility, accuracy, and timeline have influenced the adoption of gene multiplication techniques in the market. In addition, global initiatives such as the Africa Pathogen Genomics Initiative (Africa PGI) have driven the market for gene multiplication technologies. This initiative was launched in October 2020 to expand genomics-based public health pathogen surveillance.

The loop-mediated isothermal amplification (LAMP) technology segment is witnessing remarkable growth in the past few years. It is a one-step reaction and takes only 30 to 60 minutes to complete. Owing to this, it has the potential to be used in basic research in medicine and pharmacy, point-of-care testing, and cost-effective diagnosis of infectious diseases.

North America captured the largest revenue share in 2020. The U.S. is the major contributor to revenue generation. The active involvement in research activities, coupled with the presence of key players, has contributed to the growth of the regional market. Asia Pacific is anticipated to grow at the fastest rate over the forecast period owing to the entry of large biotechnological organizations, improvements in healthcare infrastructure, and increasing research activities in Asian countries. The key players in the market are undertaking various initiatives in collaboration with biopharma developers to support their product development process.

Grand View Research has segmented the global gene amplification technologies market on the basis of technology, downstream application, sample type, product, end use, and region:

• Gene Amplification Technologies Outlook (Revenue, USD Million, 2017 - 2028)
• PCR-based Amplification
• Loop-mediated Isothermal Amplification
• Nucleic Acid Sequence Based Amplification
• Strand Displacement Amplification
• Multiple Displacement Amplification
• Rolling Circle Amplification
• Ramification Amplification
• Others
• Gene Amplification Technologies Downstream Application Outlook (Revenue, USD Million, 2017 - 2028)
• Whole Genome Amplification
• Exome Sequencing
• SNP Genotyping Arrays
• Array CGH
• Hybridization
• Others
• Gene Amplification Technologies Sample Type Outlook (Revenue, USD Million, 2017 - 2028)
• Single Cell
• FFPE
• Others
• Gene Amplification Technologies Product Outlook (Revenue, USD Million, 2017 - 2028)
• Instruments
• Kits & Reagents
• Services
• Gene Amplification Technologies End-use Outlook (Revenue, USD Million, 2017 - 2028)
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Others
• Gene Amplification Technologies Regional Outlook (Revenue, USD Million, 2017 - 2028)
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K.
• Italy
• France
• Spain
• Asia Pacific
• China
• India
• Australia
• Japan
• Singapore
• Latin America
• Brazil
• Mexico
• Middle East Africa (MEA)
• South Africa
• Saudi Arabia

List of Key Players of Gene Amplification Technologies Market

• QIAGEN
• New England Biolabs
• Illumina Inc.
• Yikang Gene
• Bio-Rad Laboratories
• Silicon Biosystems
• Merck KGaA
• Promega Corporation
• Takara Bio Inc.
• Danaher Corporation
• 4basebio AG
• LGC Group
• Vazyme Biotech Co. Ltd.
• MyBioSource

Check out more studies on related to genetic engineering, conducted by Grand View Research:

• Genome Editing Market – The global genome editing market size was valued at USD 3.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 22.9% from 2021 to 2028. Increasing implementation of CRISPR genome editing technology coupled with rising synthetic gene demand in diverse biotechnology domains has primarily driven the market growth over the past few years.
• Recombinant DNA Technology Market – The global recombinant DNA technology market size was estimated at 497.7 billion in 2016. Recombinant DNA (rDNA) technology has offered scientists with unprecedented control over the genetic material. This has extended its usage in widespread applications including conventional as well as non-conventional applications.
• CRISPR And Cas Genes Market – The global CRISPR and cas genes market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028. 2020 was a remarkable year for the market as the Nobel Prize in Chemistry was received by Emmanuelle Charpentier and Jennifer A. Doudna for the breakthrough research in CRISPR/Cas9 genetic scissors for genome editing, thereby positively impacting the market.

Browse through Grand View Research's coverage of the Global Biotechnology Industry

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg